首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1922535

日本细胞治疗市场报告：按细胞类型、治疗方法、治疗领域、最终用户和地区划分（2026-2034年）

Japan Cell Therapy Market Report by Cell Type, Therapy Type, Therapeutic Area, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 117 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本细胞治疗市场规模达4.44亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到18.068亿美元，2026年至2034年的复合年增长率将达到16.88%。推动市场成长的因素包括患者知识水平的提高、政府支持的扩大以及保险覆盖范围的扩大。

细胞疗法（CT）是指将人类细胞移植到受损组织和细胞中，从而修復损伤，为治疗多种疾病提供治疗方法。这种综合疗法涵盖多种细胞类型，包括造血干细胞（HSC）、骨骼肌细胞、间质干细胞、淋巴球、树突状细胞和胰岛细胞。其应用范围不仅限于增强免疫系统以治疗癌症，还包括治疗自体免疫疾病、感染疾病、泌尿器官系统疾病、关节软骨损伤、脊髓损伤、免疫抑制和神经系统疾病。细胞疗法在再生医学的发展中发挥关键作用，促进了旨在修復和恢復受老龄化、疾病和损伤影响的组织和器官功能的创新治疗方法的开发和应用。

日本细胞治疗市场的发展趋势：

日本细胞治疗市场的主要驱动力是生物技术的快速发展。研发活动的显着成长也为这一发展提供了有力支撑，并在市场成长中发挥关键作用。此外，政府机构和私人投资者的资金流入进一步促进了细胞治疗的研究和商业化。不断扩大的临床试验活动正在验证细胞疗法的有效性和安全性，加速市场扩张。慢性病和退化性疾病的日益增加催生了对先进治疗方法的需求，从而推动了市场发展。人口老化加剧了对专门针对老龄化相关疾病的再生医学的需求，进一步增强了市场竞争力。此外，针对个别患者量身定制的个人化细胞疗法的日益普及也推动了市场成长。监管机构对细胞治疗核准流程的明确化也提振了市场前景。激烈的市场竞争推动了细胞治疗产品的创新和多元化，而罕见疾病的发病率上升也进一步支撑了市场的成长。

本报告解答的关键问题

日本细胞治疗市场目前发展状况如何？您认为未来几年它将如何发展？
新冠疫情对日本细胞治疗市场感染疾病了哪些影响？
日本细胞治疗市场按细胞类型分類的情况如何？
日本细胞疗法市场按治疗方法分類的情况如何？
日本细胞疗法市场按治疗领域分類的情况如何？
日本细胞治疗市场以最终用户分類的市场组成是怎样的？
请介绍日本细胞治疗市场价值链的各个环节。
日本细胞治疗市场的主要驱动因素和挑战是什么？
日本细胞治疗市场的结构是怎么样的？主要参与者有哪些？
日本细胞疗法市场的竞争程度如何？

Japan cell therapy market size reached USD 444.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,806.8 Million by 2034, exhibiting a growth rate (CAGR) of 16.88% during 2026-2034. Some of the factors driving the market include the increasing knowledge among patients, the rising backing from the government, and the widening scope of insurance coverage.

Access the full market insights report Request Sample

Cell therapy (CT) involves the transfer of human cells to address damage to tissues and cells, offering remedies for various medical conditions. This comprehensive approach includes various types of cells such as hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. Its applications go beyond strengthening the immune system for cancer treatment and also encompass the treatment of autoimmune and infectious diseases, urinary issues, joint cartilage damage, spinal cord injuries, compromised immune systems, and neurological disorders. It plays a crucial role in the production of regenerative medicines, facilitating the creation and implementation of innovative treatments aimed at the restoration of tissues and organs and the recovery of functions affected by aging, diseases, or injuries.

JAPAN CELL THERAPY MARKET TRENDS:

The Japan cell therapy market is primarily stimulated by the rapid progressions in biotechnology. This development is complemented by a notable increase in research and development endeavors, which are playing a significant role in the market's growth. Additionally, the influx of funding from both governmental sources and private investors is further fueling the research and commercialization of cell therapy. Furthermore, the expansion of clinical trial activities serves to authenticate the effectiveness and safety of cell therapies, thereby accelerating market expansion. The escalating prevalence of chronic and degenerative diseases is creating a demand for advanced treatment options, consequently propelling the market forward. With an aging population, there is a growing necessity for regenerative therapies tailored to age-related conditions, thus fortifying the market. Moreover, the increasing popularity of personalized cell therapies tailored to individual patients is fostering the growth of the market. Regulatory agencies are also providing clearer pathways for the approval of cell therapy, fostering a positive outlook for the market. The competitive landscape is driving innovation and diversification of cell therapy products, while the escalating incidence of rare diseases is further contributing to the market's upward trajectory.

JAPAN CELL THERAPY MARKET SEGMENTATION:

Cell Type Insights:

To get detailed segment analysis of this market Request Sample
Stem Cell Bone Marrow Blood Umbilical Cord-Derived Adipose-Derived Stem Cell Others
Bone Marrow
Blood
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Others
Non-stem Cell
Stem Cell Bone Marrow Blood Umbilical Cord-Derived Adipose-Derived Stem Cell Others
Bone Marrow
Blood
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Others
Bone Marrow
Blood
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Others
Bone Marrow
Blood
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Others
Non-stem Cell

Therapy Type Insights:

Autologous
Allogeneic
Autologous
Allogeneic

Therapeutic Area Insights:

Malignancies
Musculoskeletal Disorders
Autoimmune Disorders
Dermatology
Others
Malignancies
Musculoskeletal Disorders
Autoimmune Disorders
Dermatology
Others

End User Insights:

Hospitals and Clinics
Academic and Research Institutes
Hospitals and Clinics
Academic and Research Institutes

Regional Insights:

To get detailed regional analysis of this market Request Sample
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan cell therapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cell therapy market?
What is the breakup of the Japan cell therapy market on the basis of cell type?
What is the breakup of the Japan cell therapy market on the basis of therapy type?
What is the breakup of the Japan cell therapy market on the basis of therapeutic area?
What is the breakup of the Japan cell therapy market on the basis of end user?
What are the various stages in the value chain of the Japan cell therapy market?
What are the key driving factors and challenges in the Japan cell therapy?
What is the structure of the Japan cell therapy market and who are the key players?
What is the degree of competition in the Japan cell therapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cell Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cell Therapy Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Cell Therapy Market - Breakup by Cell Type

6.1 Stem Cell
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Bone Marrow
  - 6.1.3.2 Blood
  - 6.1.3.3 Umbilical Cord-Derived
  - 6.1.3.4 Adipose-Derived Stem Cell
  - 6.1.3.5 Others
- 6.1.4 Market Forecast (2026-2034)
6.2 Non-stem Cell
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Cell Therapy Market - Breakup by Therapy Type

7.1 Autologous
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Allogeneic
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Cell Therapy Market - Breakup by Therapeutic Area

8.1 Malignancies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Musculoskeletal Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Dermatology
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2020-2025)
- 8.5.2 Market Forecast (2026-2034)

9 Japan Cell Therapy Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)

10 Japan Cell Therapy Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Cell Type
- 10.1.4 Market Breakup by Therapy Type
- 10.1.5 Market Breakup by Therapeutic Area
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Cell Type
- 10.2.4 Market Breakup by Therapy Type
- 10.2.5 Market Breakup by Therapeutic Area
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Cell Type
- 10.3.4 Market Breakup by Therapy Type
- 10.3.5 Market Breakup by Therapeutic Area
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Cell Type
- 10.4.4 Market Breakup by Therapy Type
- 10.4.5 Market Breakup by Therapeutic Area
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Cell Type
- 10.5.4 Market Breakup by Therapy Type
- 10.5.5 Market Breakup by Therapeutic Area
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Cell Type
- 10.6.4 Market Breakup by Therapy Type
- 10.6.5 Market Breakup by Therapeutic Area
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Cell Type
- 10.7.4 Market Breakup by Therapy Type
- 10.7.5 Market Breakup by Therapeutic Area
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Cell Type
- 10.8.4 Market Breakup by Therapy Type
- 10.8.5 Market Breakup by Therapeutic Area
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Cell Therapy Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Cell Therapy Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis